🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

CMD prevalent in HFpEF Is it causal 🆚 association?? Ongoing trials to answer RX: : targeting inflammation ❤️weight loss STEP-HFpEF pooled RCT data GLP-1RA ⬇️CRP ❤️⬆️MPR at 6 months in bariatric surgery ❤️MRA in DM HFpEF spironolactone improved CFR by PET 🆚 HCTZ/placebo

Key Takeaways from Electrophysiology Late Breaking Clinical Trials #SCMR2025 Society for Cardiovascular Magnetic Resonance 🔹 Speaker: Kenneth Bilchick, MD, MSc ⚡️ AI, ECG, & CMR are shaping the future of arrhythmia management: ✅ AI-enabled ECG (AIRE Predictor) accurately predicts arrhythmic & HF risk ✅ CMR

Congratulations to Amit R. Patel for 2025 Education Award #SCMR2025 for his outstanding contributions to education and training in CMR . So well-deserved!!! UVA Department of Medicine UVA Cardiology Fellowship UVA Cardio UVA Health Christopher Kramer MD Dr. Michael Salerno M.D. P.h.D Jamieson Bourque Dr. Todd C. Villines

Key Takeaways from Late Breaking Clinical Trials on Heart Failure & Cardiomyopathies #SCMR2025 🔹 Speaker: Karolina Zareba, MD 🧲 CMR is driving innovations in HF phenotyping & treatment: ✅ DECIPHER-HFpEF: CMR vs. invasive hemodynamics, T1/T2 mapping in HFpEF ✅ PACIFIC

🚨 Late-Breaking Clinical Trial Alert! 🚨 #SCMR2025 #whyCMR Strong association between stress CMR ischemia burden and cardiovascular events in the ISCHEMIA Trial! 🫀 🧲 Post-hoc analysis confirms the prognostic power of CMR in risk stratification. Presented by Raymond Y.

a-v O2 difference in saturation varies b/w HF pts ❤️#WhyCMR T2 relaxation times are shorter for deoxygenated blood ❤️& depends not only on 02 sat, but also (Hct) & T 180 - MR sequence parameter ❤️Feasible w Arterial blood signal & Sp02 (reference) Venous blood signal, HCT

Powerful keynote by Dr. Martha Gulati at #SCMR25 on closing the gender gap in cardiovascular care. Women remain underdiagnosed, undertreated & underrepresented in research—it’s time for change! Imaging & AI can be key drivers of equity. #WomenInCardiology Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 Society for Cardiovascular Magnetic Resonance

Congratulations to Dr. Danielle Kara ! The paper she was leading was selected as MRM Highlights February 2025. Cleveland Clinic Heart, Vascular & Thoracic Cardiovascular Innovation Research Center CCF HVTI onlinelibrary.wiley.com/page/journal/1… You can read the paper here! onlinelibrary.wiley.com/doi/10.1002/mr… Staff co-authors: DebbieKwonMD Oussama Wazni Arwa Younis MD

It’s always a good morning when SagarKalahastiMD teaches about acute aortic syndromes! Great morning report presented by Yash Maniar on E-coli aortitis! venu menon Ran Lee, MD, FACC Andrew Higgins Cleveland Clinic Heart, Vascular & Thoracic #CCFCardsFam

New vision transformer approach to #WhyCMR augments accurate differentiation of cardiac #amyloidosis in patients referred for possible infiltrative cardiomyopathy & #HCM evaluation. jacc.org/doi/10.1016/j.… #AI #DeepLearning #JACCIMG #cvHCM Joshua Cockrum, MD, MS DebbieKwonMD

ECG criteria for left atrial enlargement & LVH correlated poorly with both transthoracic echocardiograms & CMR. Updating current waveform criteria may improve diagnostic accuracy of ECGs. ➡️ ahajournals.org/doi/10.1161/JA… heba wassif venu menon DebbieKwonMD Mina Chung MD CCF Cardiology Fellows

In the largest cohort of high-risk pts w/ symptomatic native AR undergoing #TAVR w/ JenaValve: 🔹The primary safety & efficacy outcomes met prespecified performance goals -Safety - 26.2% vs 40.5%, p<0.0001 -Efficacy (all-cause mortality) - 8.1% vs. 25%, p<0.0001 #ACC25 🧵1/n

This maneuver, in select cases, can increase patient’s candidacy for T-TEER. Heart team discussion involving EP is paramount when we #treatTR in patients with CIEDs. #iEcho American College of Cardiology Thanks Dr. Faza for impeccable mentorship, ChonyAlbert MD Amit Goyal MD MAS for a great discussion!

Honored to present our multidisciplinary work at #ACC25 and caught up with current practice on PAD and carotid disease American College of Cardiology Marc Gillinov DebbieKwonMD LeeKirkseyMD Cleveland Clinic Heart, Vascular & Thoracic

Cardiovascular Innovation Research Center CCF HVTI turns 3 years old today and we celebrate all the wonderful research and hard work. I feel honored to work with this talented group of scientists, engineers, and clinicians developing novel CV technologies. Cleveland Clinic Heart, Vascular & Thoracic Cleveland Clinic

We’re excited to celebrate our finalists’ research presentations on May 8! We’re also looking forward to welcoming CCF Cards alum Adnan Chhatriwalla back to Cleveland for this special occasion! venu menon Cleveland Clinic Heart, Vascular & Thoracic Lars Svensson Samir Kapadia

One of the defining aspects of our fellowship are our accomplished alumni. As a part of our fellowship research day, Dr. Chhatriwalla honored us with a noon conference on advancements in ViV TAVR and bioprosthetic valve fracture! Adnan Chhatriwalla venu menon

#HeartFailure2025 highlighting the prognostic impact of secondary #MR and stressing the role of cardiovascular imaging and Transcatheter therapies on top of #GDMT L'Institut del Cor del Germans Trias Nina Ajmone Marsan Marianna Adamo EACVI President

Age-specific troponin thresholds: considerations for the fifth universal definition of myocardial infarction in EHJ. doi.org/10.1093/eurhea… @ESCardio European Society of Cardiology Journals #age #5UDMI John William McEvoy

Treat the valve AND the myocardium when facing severe AS+amyloidosis. Both AVR and tafamidis independently ↓ mortality Dual therapy=best outcomes w/ similar survival to lone AS+AVR. Dual pathology is common (~13%) warranting RCT. tinyurl.com/2zmpht8x Bravo Thomas Treibel! 👏🏻